Nir Barzilai
MD
Professor of Medicine and Director of Institute for Aging Research
👥Biography 个人简介
Nir Barzilai leads the TAME (Targeting Aging with Metformin) trial, the first FDA-approved clinical trial targeting aging as a disease indication, with cancer incidence as a primary endpoint and epigenetic clocks as key secondary biomarkers. His studies of centenarian genetics have identified protective variants that reduce both aging rate and cancer susceptibility. He is a leader in the geroscience movement that positions aging as the primary modifiable risk factor for cancer.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Nir Barzilai 的研究动态
Follow Nir Barzilai's research updates
留下邮箱，当我们发布与 Nir Barzilai（Albert Einstein College of Medicine）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment